mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-18 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
7e-16 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-15 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-13 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-13 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-12 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-12 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-11 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.3 |
2e-11 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-11 |